Claims for Patent: 9,999,691

Summary for Patent: 9,999,691

Title:	Method for the detection of enzymatic activity with magnetically functionalized substrates
Abstract:	The present invention provides methods for detecting an enzymatic activity, the method including combining at least one magnetic particle to an enzyme substrate to form a magnetically modified substrate, reacting the magnetically modified substrate with at least one enzyme; and detecting a change in a magnetic property of the magnetically modified substrate or its cleavage products, thereby detecting an activity of said at least one enzyme, wherein the method may be applied to a human subject to detect a disease selected from the group consisting of rheumatitis, arthritis, an injury, Dupuytren\'s disease, Peyronie\'s disease, a collagen related disease, steatosis, fibrosis, cirrhosis, metastasis, tissue regeneration, cancer, coronary disease, a liver disease, a metabolic condition, an infection and an inflammatory disease.
Inventor(s):	Daich; Julian (Toledo, ES)
Assignee:
Application Number:	14/140,499
Patent Claims:	1. A method for detecting activity of an enzyme in a sample, consisting of the steps in order: (1) selecting at least one macromolecule, wherein at least one of the at least one macromolecule is selected from the group consisting of a protein, a polypeptide, a modified protein, a modified polypeptide, a glycoprotein, a lipoprotein, collagen, one or more collagen fragments, a mixture of collagen with one or more collagen fragments, and gelatin; (2) measuring and detecting the sample's magnetic property for a baseline measurement; (3)(A) (i) creating a substrate, the substrate is a plurality of magnetic particles covalently bound, by means of a process that involves silanization, to the at least one macromolecule; (ii) measuring and detecting a magnetic property of the substrate to obtain a first measurement; (iii) incorporating the substrate in the sample; or (3)(B) (i) creating a substrate in the sample, the substrate is a plurality of magnetic particles covalently bound, by means of a process that involves silanization, to the at least one macromolecule; (ii) measuring and detecting a magnetic property of the sample to obtain a first measurement; (4) measuring and detecting, after obtaining the first measurement, the magnetic property of the sample to obtain a second measurement; (5) comparing the first measurement to the second measurement; and (6) determining the substrate was degraded by the enzyme and detecting enzymatic activity if there is a change between the first measurement and the second measurement; wherein said change is indicative of at least one of (a) aggregation of said plurality of magnetic particles, (b) dispersion of said plurality of magnetic particles, (c) a change in the size of said plurality of magnetic particles, and (d) a change in the size of said substrate. 2. The method of claim 1, wherein the baseline measurement and the first measurement are the same. 3. The method of claim 1, wherein the first measurement and the second measurement are the same. 4. The method of claim 1, wherein the plurality of magnetic particles are selected from the group consisting of (a) magnetic nanoparticles, (b) superparamagnetic particles and (c) paramagnetic particles. 5. The method of claim 4, wherein the sample is an in vitro sample. 6. The method of claim 4, wherein the sample is an in vivo sample which is present in a subject. 7. The method of claim 6, wherein the enzymatic activity is indicative of a disease or condition. 8. The method of claim 7, wherein said disease or condition is selected from the group consisting of rheumatitis, arthritis, an injury, connective tissue condition related disease, Dupuytren's disease, Peyronie's disease, a collagen related disease, steatosis, fibrosis, cirrhosis, metastasis, tissue regeneration, cancer, coronary disease, a liver disease, a metabolic condition, an infection and an inflammatory disease. 9. The method of claim 1, wherein creating the substrate of step (3)(B) is effected in situ in said sample. 10. The method of claim 1, wherein creating the substrate of step (3)(A) is effected ex situ not in said sample. 11. The method of claim 1, wherein the enzyme is selected from the group consisting of a metal-dependent enzyme, a protease, a lipase, a lipoprotein lipase, a hormone sensitive lipase, a metalloprotease, a matrix metallo-proteinase (MMP), a collagenase and a gelatinase. 12. The method of claim 1, wherein the magnetic property is detected by a method selected from the group consisting of nuclear magnetic resonance (NMR), magnetic resonance imaging (MRI), electronic paramagnetic resonance (EPR), magnetometry, Mossbauer spectrometry, electromagnetic inductance, atomic force microscopy, magnetorelaxometry and a combination thereof. 13. The method of claim 1, wherein said magnetic property is measured indirectly by measuring at least one of a member of the group consisting of a signal intensity, T1 relaxation, T2 relaxation, a diffusion parameter and a response to a signal saturation. 14. The method of claim 13, wherein said determining includes determining if a change in said magnetic property has been observed. 15. The method of claim 14, wherein said change in said magnetic property is an at least partial change from superparamagnetism to paramagnetism. 16. The method of claim 1, wherein said aggregation or said change in the size of said plurality of magnetic particles is a consequence of magnetic attraction between magnetic particles. 17. The method of claim 1, wherein the at least one macromolecule is a first at least one macromolecule combined to a second at least one macromolecule. 18. The method of claim 17 wherein the first macromolecule is covalently bound to the plurality of magnetic particles. 19. A method for detecting the integrity of a substrate for an enzyme, consisting of the steps in order: selecting at least one macromolecule, wherein at least one of the at least one macromolecule is selected from the group consisting of a protein, a polypeptide, a modified protein, a modified polypeptide, a glycoprotein, a lipoprotein, collagen, one or more collagen fragments, a mixture of collagen with one or more collagen fragments, and gelatin; creating the substrate, the substrate is a plurality of magnetic particles covalently bound, by means of a process that involves silanization, to the at least one macromolecule; incorporating the substrate in a sample; measuring through a magnetic based detection method a magnetic property of the sample to obtain a first measurement; measuring, through the magnetic based detection method and after obtaining the first measurement, a magnetic property of the sample to obtain a second measurement; comparing the first measurement to the second measurement; and determining there is degradation of the substrate by an enzyme in the sample if there is a change between the first measurement and the second measurement; wherein said change is indicative of at least one of (a) aggregation of said plurality of magnetic particles, (b) dispersion of said plurality of magnetic particles, (c) a change in the size of said plurality of magnetic particles, and (d) a change in the size of said substrate. 20. A method for detecting the activity of at least one enzyme in a sample, consisting of the steps in order: selecting at least one macromolecule, wherein at least one of the at least one macromolecule is selected from the group consisting of a protein, a polypeptide, a modified protein, a modified polypeptide, a glycoprotein, a lipoprotein, collagen, one or more collagen fragments, a mixture of collagen with one or more collagen fragments, and gelatin; forming a substrate, the substrate is a plurality of magnetic particles covalently bound, by means of a process that involves silanization, to the at least one macromolecule; incorporating the substrate in the sample; measuring through a nuclear magnetic resonance-based detection method a T1 or T2 relaxation time of the sample to obtain a first measurement; measuring, through the nuclear magnetic resonance-based detection method and after obtaining the first measurement, the T1 or T2 relaxation time of the sample to obtain a second measurement; comparing the first measurement to the second measurement; and determining there is an aggregation of the magnetic particles as a consequence of enzymatic digestion of the substrate thus indicating the presence of enzymatic activity in the sample.

Details for Patent 9,999,691

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2030-01-22